Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Poster Session 04

Wednesday 04/16/08
07:00 AM - 10:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Movement Disorders, Neuroepidemiology/Health Services and Outcomes Research, Behavioral Neurology, Aging and Dementia, Anterior Horn, Cerebrovascular Disease and Interventional Neurology, Neural Repair/Rehabilitation, MS and Related Diseases, Muscle Disease/Neuromuscular Junction
No CME available
Event Timeline
07:00 AM - 08:30 AM Break
07:00 AM - 10:00 AM Abstract 001 - Early Versus Delayed Bilateral Subthalamic Deep Brain Stimulation for Parkinson's Disease: A Decision Analysis
07:00 AM - 10:00 AM Abstract 002 - Medium Frequency Subthalamic Stimulation for Axial Symptoms in Advanced Parkinson's Disease
07:00 AM - 10:00 AM Abstract 003 - Pallidal Stimulation and Subthalamic Stimulation in Parkinson's Disease Patients May Lead to Equivalent Dose Reductions in Postoperative Doses of Medications
07:00 AM - 10:00 AM Abstract 004 - Walking and Counting: Are PD Patients Doing the Same with Levodopa and Subthalamic Deep Brain Stimulation?
07:00 AM - 10:00 AM Abstract 005 - Assessing the Microlesion Effect of STN DBS Electrode Placement with FDG PET
07:00 AM - 10:00 AM Abstract 006 - Optokinematic Analysis of the Effect of Modified STN DBS Frequencies on Gait Disorders in Advanced Parkinson's Disease
07:00 AM - 10:00 AM Abstract 007 - Repetitive Subthalamic Stimulation Disrupts Synaptic Transmission Recorded in Substantia Nigra Pars Reticulata Neurons
07:00 AM - 10:00 AM Abstract 008 - Unilateral Thalamic or Subthalamic Nucleus DBS in Tremor Predominant PD: Differential Effects on Upper Limb Kinematics
07:00 AM - 10:00 AM Abstract 009 - Relief of Acquired Stuttering Associated with Parkinson Disease by Unilateral Left Subthalamic Brain Stimulation
07:00 AM - 10:00 AM Abstract 010 - Modeling Field Steering in the Brain with Segmented Electrodes: Next Generation Deep Brain Stimulation Therapy
07:00 AM - 10:00 AM Abstract 011 - Ketogenic Diet Prevents Cerebral Hypoxic Neurodegeneration in a Rat Model of Posthypoxic Myoclonus
07:00 AM - 10:00 AM Abstract 012 - Cerebral Magnetic Resonance Imaging Findings in Wilson's Disease: Possible Relationship with Portal Hypertension
07:00 AM - 10:00 AM Abstract 013 - Swiss Cheese Striatum: Clinical Spectrum
07:00 AM - 10:00 AM Abstract 014 - Successful and Rapid Improvement of Tardive Dyskinesia with a Combination of Tetrabenazine, Clonazepam and Clozapine at Low Doses
07:00 AM - 10:00 AM Abstract 015 - Improvement of Essential Tremor after Cerebellar Hemorrhage
07:00 AM - 10:00 AM Abstract 016 - Anxiety in Parkinson's Disease: Clinical and Demographic Correlates
07:00 AM - 10:00 AM Abstract 017 - Tremor in X-Linked Recessive Spinobulbar Muscular Atrophy (Kennedy's Disease)
07:00 AM - 10:00 AM Abstract 018 - Arginine Does Not Distinguish Cerebellar Multiple System Atrophy from Other Ataxias
07:00 AM - 10:00 AM Abstract 019 - Evidence for Conversion of L-Dopa to Dopamine in Striatal Glial Cells
07:00 AM - 10:00 AM Abstract 020 - Deep Brain Stimulation (DBS) in Patients with Parkinson's Disease (PD) Improves Motor Execution Rather Than Motor Planning
07:00 AM - 10:00 AM Abstract 021 - Neuropsychological Functioning Following Subthalamic Gene Therapy for Parkinson's Disease
07:00 AM - 10:00 AM Abstract 022 - The Prevalence and Clinical Significance of Fatigue Following Deep Brain Surgery in Parkinson's Disease
07:00 AM - 10:00 AM Abstract 023 - Changes in Emotional Versus Physical Symptoms of Depression Following Sub-Thalamic Nucleus Deep Brain Stimulation for Parkinson's Disease
07:00 AM - 10:00 AM Abstract 024 - Dopaminergic Dysregulation Syndrome in Parkinsons Disease: A Prospective Study in Patients Treated by Subthalamic Deep Brain Stimulation
07:00 AM - 10:00 AM Abstract 025 - Does Subthalamic Stimulation for Parkinson's Disease Improve Spouses? A One-Year Study of Mood, Burden and Quality of Life
07:00 AM - 10:00 AM Abstract 026 - Patient Centered Outcomes for Deep Brain Stimulation
07:00 AM - 10:00 AM Abstract 027 - Dopasensitive Axial Involvement in Parkinson's Disease: A Long Term Evaluation under Subthalamic Deep Brain Stimulation
07:00 AM - 10:00 AM Abstract 028 - The New Phenotype of Parkinson's Disease: The Post-Subthalamic Stimulation Era
07:00 AM - 10:00 AM Abstract 029 - Long-Term Gait Deterioration after Bilateral STN DBS Is Not Due to the Natural Progression of Parkinson's Disease
07:00 AM - 10:00 AM Abstract 030 - Intra-Operative X-Ray To Measure Distance between DBS Leads: A Reliability Study
07:00 AM - 10:00 AM Abstract 031 - Neuroanatomical Correlates of Extraversion in Neurodegenerative Disease
07:00 AM - 10:00 AM Abstract 032 - Parkinson's Disease, Subthalamic Nucleus and Emotional Processing
07:00 AM - 10:00 AM Abstract 033 - The [alpha]2 and [alpha]5 nAchR Subunits Are Critical for Nicotine Withdrawal
07:00 AM - 10:00 AM Abstract 034 - Brain Regions for Smile and Panic Phenomena Induced during Intraoperative Test Stimulation in Obsessive Compulsive Disorder (OCD)
07:00 AM - 10:00 AM Abstract 035 - Pregabalin Improves Pain in Fibromyalgia (FM) Patients Regardless of Baseline Anxiety and Depression Levels
07:00 AM - 10:00 AM Abstract 036 - Cognitive, Functional and Behavioral Factors Associated with the Burden of Caring for Geriatric Patients with Cognitive Impairment or Depression: Evidence from a South American Sample
07:00 AM - 10:00 AM Abstract 037 - Is Perception of Causes of Illness Related to Psychological Well-Being in ALS Patients?
07:00 AM - 10:00 AM Abstract 038 - Pregabalin Pain Changes Associate with Anxiety and Depression Changes in Fibromyalgia Patients
07:00 AM - 10:00 AM Abstract 039 - Number Impairment in Corticobasal Degeneration
07:00 AM - 10:00 AM Abstract 040 - Compromised Verb Associative Knowledge in Frontotemporal Dementia
07:00 AM - 10:00 AM Abstract 041 - Selective Number-Related Comprehension Deficits in Corticobasal Degeneration
07:00 AM - 10:00 AM Abstract 042 - The Neural Basis of Left-Lateralized and Bilateral Language Functions in Children and Young Adults
07:00 AM - 10:00 AM Abstract 043 - Verb and Noun Knowledge in Amyotrophic Lateral Sclerosis
07:00 AM - 10:00 AM Abstract 044 - Language Specific, Non-Fluent Aphasia in a Bilingual Patient with Progressive Supranuclear Palsy
07:00 AM - 10:00 AM Abstract 045 - Cortical Pathways of Nouns and Verbs' Processing
07:00 AM - 10:00 AM Abstract 046 - Wernicke's Aphasia Caused by Broca's Area Infarction: A PET Follow-Up Study
07:00 AM - 10:00 AM Abstract 047 - Elevated CSF P-tau181 and Total-tau and Reduced P-tau181/T-tau Ratio in Pre-Symptomatic Familial Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 048 - Feasibility of Biomarker-Based Alzheimer's Disease Prevention Trials
07:00 AM - 10:00 AM Abstract 049 - Brain and Ventricular Volumetric Changes in Patients with Frontotemporal Lobar Degeneration: Results of a Longitudinal, Multicenter Study
07:00 AM - 10:00 AM Abstract 050 - Self-Administered Gerocognitive Examination (SAGE): Validity and Reliability of a Brief Cognitive Screening Instrument for Mild Cognitive Impairment (MCI) and Early Dementia
07:00 AM - 10:00 AM Abstract 051 - Comparison of Coated-Platelet Production between Patients with Alzheimer Disease and Frontotemporal Dementia
07:00 AM - 10:00 AM Abstract 052 - Validation of a Self-Administered Computerized Screening Test for Cognitive Impairment and Dementia
07:00 AM - 10:00 AM Abstract 053 - Protein Expression and Phosphorylation Profiles from Blood Lymphocytes Can Distinguish Patients with Alzheimer Disease from Age-Matched Controls
07:00 AM - 10:00 AM Abstract 054 - Plasma A[beta]40 Is Associated with Very Early Cognitive Deficits in a Population-Based Sample of Older People
07:00 AM - 10:00 AM Abstract 055 - Informant-Based Detection of Cognitive Decline in a Population-Based Sample of African American Participants
07:00 AM - 10:00 AM Abstract 056 - Hippocampal Atrophy, Cortical Infarctions and Decreased NAA/Cr Have Additive Effects on the Risk of Progression to Dementia in MCI
07:00 AM - 10:00 AM Abstract 057 - Relation of Hypertension to Mild Cognitive Impairment
07:00 AM - 10:00 AM Abstract 058 - Impact of White Matter Hyperintensity Volume Progression on Rate of Cognitive and Motor Decline
07:00 AM - 10:00 AM Abstract 059 - Hypoglycemic Episodes Increase the Risk of Dementia in Elderly Patients with Diabetes Mellitus
07:00 AM - 10:00 AM Abstract 060 - Diabetes and Cognitive Systems in Older Black and White Persons
07:00 AM - 10:00 AM Abstract 061 - Apolipoprotein E (APOE) e4 Selectively Accelerates Age-Related Memory Decline
07:00 AM - 10:00 AM Abstract 062 - Duration of Diabetes Mellitus, Insulin Therapy, and Diabetic Complications Are Associated with Mild Cognitive Impairment: The Mayo Clinic Study of Aging
07:00 AM - 10:00 AM Abstract 063 - Vascular Conditions as Risk Factors for Dementia amongst Five Medicare Elderly Cohorts
07:00 AM - 10:00 AM Abstract 064 - Vascular Risk Factors Predict Executive Cognitive Impairment in Aging, MCI, and Dementia
07:00 AM - 10:00 AM Abstract 065 - Moderate Physical Exercise Is Associated with a Reduced Risk of Mild Cognitive Imapirment: A Population-Based Study
07:00 AM - 10:00 AM Abstract 066 - Predictors of Progression from Mild Cognitive Impairment (MCI) to Dementia in a Combined Clinical and Community Population
07:00 AM - 10:00 AM Abstract 067 - Midlife Serum Total Cholesterol and Risk of Alzheimer's Disease and Vascular Dementia Three Decades Later
07:00 AM - 10:00 AM Abstract 068 - Height and Incidence of Dementia. The 3C Study
07:00 AM - 10:00 AM Abstract 069 - Coagulation Derangements Associated to Markers of Inflammation in Vascular Dementia
07:00 AM - 10:00 AM Abstract 070 - Relation of Serum Markers of Oxidative Stress to Mild Cognitive Impairment and Cognitive Decline
07:00 AM - 10:00 AM Abstract 071 - Impact of Alcohol Use, Smoking and Apolipoprotein-E Epsilon 4 Allele (APOE [epsilon]4) on Age of Onset of Late Onset Alzheimers Disease (LOAD)
07:00 AM - 10:00 AM Abstract 072 - Cardiorespiratory Fitness and Brain Atrophy in Early Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 073 - Smoking Is Associated with Increased Brain Atrophy Rates on Serial MRI Scans in Men but Not Women with Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 074 - Associations between White Matter Lesions, Plasma Total Homocysteine and Methylenetetrahydrofolate Reductase Polymorphism in Alzheimer's Disease
07:00 AM - 10:00 AM Abstract 075 - Diabetes Mellitus: Risk or Protective Factor in ALS?
07:00 AM - 10:00 AM Abstract 076 - Prospective Studies on Smoking and Risk of Amyotrophic Lateral Sclerosis
07:00 AM - 10:00 AM Abstract 077 - The Piemonte and Valle d'Aosta ALS Register (PARALS): A 10-Year Epidemiological Prospective Study
07:00 AM - 10:00 AM Abstract 079 - Association of the Periodontitis Pathogen Porphyromonas gingivalis with Poor Memory: Analysis of the Third National Health and Nutrition Examination Survey (NHANES-III)
07:00 AM - 10:00 AM Abstract 080 - Risk of Incident Parkinson's Disease and Parkinsonism in Essential Tremor: A Population-Based Study
07:00 AM - 10:00 AM Abstract 081 - Prenatal and Early Life Factors and Risk of Parkinson's Disease
07:00 AM - 10:00 AM Abstract 082 - Different Prevalence Rates of Parkinson's Disease in Urban and Rural Areas: Population-Based Study in Taiwan
07:00 AM - 10:00 AM Abstract 083 - Factors Associated with a Steep Rise in the Incidence of MS on Crete over the past 25 Years
07:00 AM - 10:00 AM Abstract 084 - Cats as Domestic Pets Reduce the Risk of Cardiovascular Diseases. Results from the Second National Health and Nutrition Examination Study Mortality Follow-Up Study
07:00 AM - 10:00 AM Abstract 085 - A Randomized, Placebo-Controlled, Sequential Trial of Valproic Acid in ALS
07:00 AM - 10:00 AM Abstract 086 - A Phase I-II Multicenter Study on G-CSF in Amyotrophic Lateral Sclerosis (STEMALS)
07:00 AM - 10:00 AM Abstract 087 - Transplantation of Neural Precursor Cells into the Central Nervous System of ALS Patients: the First Neuropathological Study
07:00 AM - 10:00 AM Abstract 088 - Pyrimethamine Reduces SOD1 Levels in Familial ALS: Assessment of Efficacy, Safety and Tolerability
07:00 AM - 10:00 AM Abstract 089 - Progesterone as a New Treatment Option for Amyotrophic Lateral Sclerosis Patients: Open Trial and Survival Analysis
07:00 AM - 10:00 AM Abstract 090 - Angiogenin Haplotypes in a Swedish Sporadic ALS Dataset
07:00 AM - 10:00 AM Abstract 091 - Evidence of Reduced Frequency of ALS in an Ethnically Mixed Population: A Population-Base Mortality Study
07:00 AM - 10:00 AM Abstract 092 - Paraplegin Mutations in Apparently Sporadic Adult-Onset Upper Motor Neuron Syndromes
07:00 AM - 10:00 AM Abstract 093 - Evidence for a Chronic and Long Lasting Hyperactivity in ALS Patients
07:00 AM - 10:00 AM Abstract 094 - Systemic Low-Grade Inflammation in Patients with Amyotrophic Lateral Sclerosis
07:00 AM - 10:00 AM Abstract 095 - Profile of Amyotrophic Lateral Sclerosis with and without Vascular Risk Factors: Results of a Clinical Database Study
07:00 AM - 10:00 AM Abstract 096 - Diffusion Tensor MRI of the Cervical Cord as a Tool To Monitor Disease Progression in ALS
07:00 AM - 10:00 AM Abstract 097 - Whole-Brain Metabolite Alterations and Their Correlations with Upper Motor Neuron (UMN) Function Measures in Amyotrophic Lateral Sclerosis (ALS)
07:00 AM - 10:00 AM Abstract 098 - Interleukin 4 in ALS
07:00 AM - 10:00 AM Abstract 099 - Elevated Plasma Homocysteine Levels in Patients with Amyotrophic Lateral Sclerosis
07:00 AM - 10:00 AM Abstract 100 - Study of Corticospinal Tract in Amyotrophic Lateral Sclerosis Using Diffusion Tensor Imaging
07:00 AM - 10:00 AM Abstract 101 - Combined Motor Cortex Proton Magnetic Resonance Spectroscopy (1H-MRS) and Corticospinal Tract (CST) Magnetization Transfer Ratio (MTR) Predict Disease Progression and Survival in Amyotrophic Lateral Sclerosis (ALS): A Target for Clinical Trials in ALS
07:00 AM - 10:00 AM Abstract 102 - Inflammatory Cytokines as Predictors of Clinical Outcome after Acute Ischemic Stroke
07:00 AM - 10:00 AM Abstract 103 - Metabolic Syndrome and Ischemic Stroke/TIA: Is There a Relationship?
07:00 AM - 10:00 AM Abstract 104 - Lower Serum Triglycerides: Potential Markers for Poor Outcomes in Acute Ischemic Stroke
07:00 AM - 10:00 AM Abstract 105 - Hyperglycemia as a Prognostic Factor in Ischemic Stroke. Results of a Multicentric Study
07:00 AM - 10:00 AM Abstract 106 - Impairment in Glomerular Barrier or Filtration Rate Is Associated with Stroke Occurrence
07:00 AM - 10:00 AM Abstract 107 - Depression in High-Density Lipoprotein Levels at Ischemic Stroke Presentation
07:00 AM - 10:00 AM Abstract 108 - Relationship of Post Acute Ischemic Stroke Ionised Magnesium and Calcium to Serum Troponin and Mortality
07:00 AM - 10:00 AM Abstract 109 - Tau Protein as a Serum Marker of Ischemic Stroke
07:00 AM - 10:00 AM Abstract 110 - Granulocyte Colony-Stimulating-Factor Is an Independent Prognostic Factor of Poor Outcome in Patients with Acute Ischemic Stroke
07:00 AM - 10:00 AM Abstract 111 - Cell Death Pathways; Activated Caspase-3 and PARP in Ischemic Human Stroke
07:00 AM - 10:00 AM Abstract 112 - Cryptogenic Stroke May Be Associated with Lower High-Density Lipoprotein Levels
07:00 AM - 10:00 AM Abstract 113 - Plasma Homocysteine as a Risk Factor for Strokes in Ghanaian Adults
07:00 AM - 10:00 AM Abstract 114 - Absence of Association between a Risk Gene for Myocardial Infarction and Common Stroke
07:00 AM - 10:00 AM Abstract 115 - The ER-alpha PvuII Polymorphism Contributes to the Pathogenesis of Intracranial Aneurysm
07:00 AM - 10:00 AM Abstract 116 - Variability of Blood Pressure Management in Intracerebral Hemorrhage Does Not Affect Outcome
07:00 AM - 10:00 AM Abstract 117 - Seizures Following Intracerebral Hemorrhage: Risks and Implications for Therapy
07:00 AM - 10:00 AM Abstract 118 - Prediction of Mortality after Aneurysmal Subarachnoid Hemorrhage: The Importance of the Admittance Blood Glucose
07:00 AM - 10:00 AM Abstract 119 - Initial Perihematomal Edema Volume Is an Independent Predictor of Outcome at 3 Months Follow-Up in Patients with Spontaneous Intracerebral Hemorrhage (SICH)
07:00 AM - 10:00 AM Abstract 120 - Risk Factors of Progressive Motor Deficits in Patients with Acute Pontine Infarction
07:00 AM - 10:00 AM Abstract 121 - Cerebral Venous Sinus Thrombosis Etiologies in Adults: A Comprehensive Review
07:00 AM - 10:00 AM Abstract 122 - Transfusion of Blood Products Is an Independent Predictor of Mortality in Acute Ischemic Stroke Patients
07:00 AM - 10:00 AM Abstract 123 - Validation of the ABCD Score To Predict Stroke Risk after TIA: A Population-Based Study
07:00 AM - 10:00 AM Abstract 124 - Impact of Modifiable Etiologic Factors on the Burden of Stroke: The Rotterdam Study
07:00 AM - 10:00 AM Abstract 125 - Hyperglycemia Does Not Predict Functional Outcome in Lacunar Strokes
07:00 AM - 10:00 AM Abstract 126 - Infections and Risk of Ischemic Stroke: Causal or Casual Relationship?
07:00 AM - 10:00 AM Abstract 127 - A Comparison of Holter Monitoring and Continuous Cardiac Telemetry in the Detection of Arrhythmias Following Ischemic Stroke or Transient Ischemic Attack
07:00 AM - 10:00 AM Abstract 128 - Presence of an Ipsilateral Fetal Posterior Cerebral Artery in Stroke Patients Correlates with Better Clinical Outcomes
07:00 AM - 10:00 AM Abstract 129 - Sex Disparities in Ischemic Stroke Care and Outcome in an Emerging Country. The Argentinian National Stroke Registry (ReNACer)
07:00 AM - 10:00 AM Abstract 130 - Combined Assessment of NSE, S 100, and Somatosensory Evoked Potentials for the Prediction of Short Term Outcome in Acute Ischemic Stroke
07:00 AM - 10:00 AM Abstract 131 - Trend of Stroke Hospitalization and Changes in Hospital Outcomes in Aragon (Spain), 1999-2006
07:00 AM - 10:00 AM Abstract 132 - Effect of Ventriculostomy on Outcome in Intracranial Hemorrhage with Intraventricular Extension
07:00 AM - 10:00 AM Abstract 133 - Thrombolytic Therapy for Acute Stroke in Pakistan
07:00 AM - 10:00 AM Abstract 134 - Escalating Levels of Access to In-Hospital Care and Stroke Mortality
07:00 AM - 10:00 AM Abstract 135 - Participation in Peer-Led Support Groups Improves Use of Secondary Stroke Prevention Measures
07:00 AM - 10:00 AM Abstract 136 - Incidence of Stroke in Alaska Native People
07:00 AM - 10:00 AM Abstract 137 - Stroke Outcome in Those over 80: A Canadian Study of the Approaching "Silver Tsunami"
07:00 AM - 10:00 AM Abstract 138 - Risk Factors for Hospital Acquired Pneumonia among Stroke Patients
07:00 AM - 10:00 AM Abstract 139 - JCAHO Primary Stroke Center Core Measures: Influence of Stroke Care Unit
07:00 AM - 10:00 AM Abstract 140 - Stroke Outcomes Better for Patients Treated by Neurologists
07:00 AM - 10:00 AM Abstract 141 - The Impact of ACGME Duty Hours Regulations and the July Phenomenon on Stroke Outcomes
07:00 AM - 10:00 AM Abstract 142 - Importance of Subjective Symptoms for Health-Related Quality of Life in Post-Stroke Patients - Assessment Using SF-36 (OASIS Study)
07:00 AM - 10:00 AM Abstract 143 - On the Use of Simon's Two-Stage Optimal Design for Phase II Trials in Stroke Recovery
07:00 AM - 10:00 AM Abstract 144 - Clinically Meaningful Differences of the Ashworth Scale in Patients Suffering from Chronic Post-Stroke Upper Limb Spasticity
07:00 AM - 10:00 AM Abstract 145 - Subjective Postural Vertical in Patients with Lateropulsion Following Stroke: A Pilot Comparison Study
07:00 AM - 10:00 AM Abstract 146 - Consistent Efficacy of Botulinum Toxin Type A in a Meta-Analysis from Seven Multicenter Studies of Upper Limb Spasticity in Chronic Post-Stroke Patients
07:00 AM - 10:00 AM Abstract 147 - Retinal Microperimetry as a Means To Assess Visual Field Expansion in Visual Restoration Therapy
07:00 AM - 10:00 AM Abstract 148 - Differential Effects of High-Frequency rTMS on Movement Kinematics and Neural Activation in Subcortical and Cortical MCA Stroke
07:00 AM - 10:00 AM Abstract 149 - A Pilot Study of Activity-Based Therapy in Upper Extremity Motor Recovery Post Stroke. A Randomized Control Trial
07:00 AM - 10:00 AM Abstract 150 - Rehabilitation Hospital Versus Nursing Home Setting for Rehabilitation Following Stroke: A Case Matched Controlled Study, Phase 2
07:00 AM - 10:00 AM Abstract 151 - Proportional Motor Improvement: A New Rule in Stroke Recovery?
07:00 AM - 10:00 AM Abstract 152 - Effect of Antidepressant Choice on FIM Efficiency during Inpatient Rehabilitation Following Stroke
07:00 AM - 10:00 AM Abstract 153 - Brain MR Changes and Cognitive Impairment May Predict Short-Term Disease Progression in Benign Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 154 - Memory, Working Memory, and Processing Speed Significantly Improve after Participation in a Six-Week Comprehensive Rehabilitation Cognitive Program
07:00 AM - 10:00 AM Abstract 155 - EDSS and MRI Burden of Disease Predict Cognitive Status at 16 Years: Data from the IFNB-1b Long Term Follow-Up Study
07:00 AM - 10:00 AM Abstract 156 - Progression of Disability over 2 Years Predicts Disability at 8 Years in Relapsing MS: Analysis from the Phase 3 Clinical Trial of Intramuscular Interferon Beta-1a
07:00 AM - 10:00 AM Abstract 157 - The Burden of Mental Comorbidity in Multiple Sclerosis: Frequent, Underdiagnosed, and Under-Treated
07:00 AM - 10:00 AM Abstract 158 - Adding a Vision Increases the Capacity of the Multiple Sclerosis Functional Composite (MSFC) To Identify Reductions in Neurological Impairment and Quality of Life
07:00 AM - 10:00 AM Abstract 159 - Predictors of Disability in Secondary Progressive MS: A Multimodal MRI Study
07:00 AM - 10:00 AM Abstract 160 - Screening for Cognitive Impairment in Multiple Sclerosis (MS): Evaluation of the HIV Dementia Scale (HDS)
07:00 AM - 10:00 AM Abstract 161 - Decreased Volume of Subcortical Activation during Complex Finger Tapping Correlates with Increasing Level of Fatigue in Patients with MS
07:00 AM - 10:00 AM Abstract 162 - Low-Contrast Letter Acuity Scores Reflect Vision-Specific and Overall Health-Related Quality of Life in Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 163 - Remote Automated Neuropsychological Assessment Metrics (ANAM[trade]) Measures Predict Performance on Neuropsychological Measures Used in Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 164 - Identification of Cognitive Impairment in MS Patients Using the Automated Neuropsychological Assessment Metrics (ANAM[trade]) Computerized Test System Administered over the Internet
07:00 AM - 10:00 AM Abstract 165 - The Computerized Automated Neuropsycology Assessment Metrics as Triage Measure for Assessing the Cognitive Impairment of Patients with Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 166 - Pre-Existing Comorbidity in MS Is Associated with Greater Diagnostic Delays and Greater Disability at Diagnosis
07:00 AM - 10:00 AM Abstract 167 - Clinical and Neuropsychological Predictors of Neuropsychiatric Symptoms in Subjects with MS and Cognitive Impairment
07:00 AM - 10:00 AM Abstract 168 - Cognitive Performance in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis (CIS): Baseline Data from CogniCIS, a Multinational Longitudinal Study
07:00 AM - 10:00 AM Abstract 169 - Natalizumab Reduces Multiple Sclerosis Severity: Analysis of Patients from the AFFIRM and SENTINEL Studies Using the Multiple Sclerosis Severity Scale
07:00 AM - 10:00 AM Abstract 170 - Relationship between Cognitive Impairment and Magnetic Resonance Imaging Disease Parameters in Patients with Early Relapsing-Remitting Multiple Sclerosis: Results from the Multicenter COGIMUS (COGnition Impairment in MUltiple Sclerosis) Study
07:00 AM - 10:00 AM Abstract 171 - Profiles of Performance of the PASAT with Dyad Score in Different Subtypes of Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 172 - Variability in the EDSS: What Does It Mean for Progression?
07:00 AM - 10:00 AM Abstract 173 - Quantitative Functional Tests and Patient Self-Report: Assessing the Relative Sensitivities of the Timed 25-Foot Walk and the 9-Hole Peg Test to Worsening Reported by Patients with Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 174 - Cognitive Performance in Early Multiple Sclerosis (MS): Baseline Data from CogniMS, a Multinational Longitudinal Study
07:00 AM - 10:00 AM Abstract 175 - Correlations between Auditory Consonant Trigram Test, Paced Auditory Serial Addition Test Health-Related Quality of Life during and after Treatment of Relapses in Patients with Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 176 - Effect of Relapse on Cognition for Patients with Multiple Sclerosis (MS)
07:00 AM - 10:00 AM Abstract 177 - Toward a Specific Revalidation Regarding Cognitive Troubles in Multiple Sclerosis (MS): PROCOG-SEP
07:00 AM - 10:00 AM Abstract 178 - The Interferon Beta-1b 16-Year Long-Term Follow-Up Study: Neutralizing Antibodies and Clinical Outcomes
07:00 AM - 10:00 AM Abstract 179 - Predictors of Poor Sleep Quality in Multiple Sclerosis
07:00 AM - 10:00 AM Abstract 180 - Patients with Multiple Sclerosis Have Higher Rates of Sleep Disturbances: A Case-Control Study
07:00 AM - 10:00 AM Abstract 181 - Pain in Patients with Multiple Sclerosis: Effects of Natalizumab
07:00 AM - 10:00 AM Abstract 182 - The Contribute of Cerebrospinal Fluid Analysis to the Diagnosis of Multiple Sclerosis after the First Demyelinating Attack
07:00 AM - 10:00 AM Abstract 183 - Treatment with the Poly-ADP-Ribosylation Inhibitor, Nicotinamide Protects Against Increased Injury Susceptibility of CA1 Hippocampal Neurons in Aged Animals
07:00 AM - 10:00 AM Abstract 184 - Role of Tooth Loss in Mechanisms of Dysphagia: A Quantitative Study Using Tongue Pressure Measurements in Stroke Patients
07:00 AM - 10:00 AM Abstract 185 - Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Ischemic Stroke
07:00 AM - 10:00 AM Abstract 186 - GCSF-Mobilized Hematopoietic Stem Cells in CNS Ischemic Lesion
07:00 AM - 10:00 AM Abstract 187 - A Case of Neuropsychological and SPECT Findings after Bilateral Fornix Infarction
07:00 AM - 10:00 AM Abstract 188 - Quantitative-Genetic Analysis of Vertebral Artery Hypoplasia in Humans
07:00 AM - 10:00 AM Abstract 189 - Neuroprotective Effects of Carnosine and Its Analogues Against Focal Cerebral Ischemia in Mice
07:00 AM - 10:00 AM Abstract 190 - Taxol Reduces Infarct Size in Rat Stroke Model
07:00 AM - 10:00 AM Abstract 191 - Fidelity of Gamma-Glutamyl Transferase in Differentiating Skeletal Muscle from Liver Damage
07:00 AM - 10:00 AM Abstract 192 - Clinical Significance of Measurement of Aldolase in Myopathies
07:00 AM - 10:00 AM Abstract 193 - Diffusion Weighted MR Imaging of Denervated Skeletal Muscle: An Experimental and Clinical Study
07:00 AM - 10:00 AM Abstract 194 - Quantification and Standardization of Ultrasound Imaging of Skeletal Muscle Using Backscatter Analysis
07:00 AM - 10:00 AM Abstract 195 - Health Status in Non-Dystrophic Myotonia: Close Relation with Pain and Fatigue
07:00 AM - 10:00 AM Abstract 196 - The Use of a Brief Neuropsychological Testing Battery in a Treatment Trial for Myotonic Dystrophy Type 1 (DM1) Patients
07:00 AM - 10:00 AM Abstract 197 - Quality of Life in Patients with Inclusion Body Myositis
07:00 AM - 10:00 AM Abstract 198 - The Relative Contributions of Disease Severity, Mood and Illness Perceptions on the Quality of Life of Those with Muscle Disease
07:00 AM - 10:00 AM Abstract 199 - Palliative Care Services in Families of Patients with Duchenne Muscular Dystrophy
Faculty Disclosures
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
David C. Preston, MD, FAAN Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Carlayne E. Jackson, MD, FAAN Dr. Jackson has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for AAN. The institution of Dr. Jackson has received research support from NIH. The institution of Dr. Jackson has received research support from Massachussetts General Hospital.
Douglas W. Scharre, MD, FAAN Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from Percision Medicine. The institution of Dr. Scharre has received research support from Premier Research Group. The institution of Dr. Scharre has received research support from Genetch. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from Cerevel Therapeutics. The institution of Dr. Scharre has received research support from Janssen. The institution of Dr. Scharre has received research support from Cassava. The institution of Dr. Scharre has received research support from UniQure. The institution of Dr. Scharre has received research support from Cognition Therapeutics. The institution of Dr. Scharre has received research support from Cognitive Research Corporation. The institution of Dr. Scharre has received research support from EIP. The institution of Dr. Scharre has received research support from Cognito. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Joseph Jankovic, MD, FAAN Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Elliot M. Frohman, MD, FAAN Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Frohman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date. Dr. Frohman has received publishing royalties from a publication relating to health care.
J. E. Ahlskog, MD, PhD Dr. Ahlskog has received publishing royalties from a publication relating to health care.
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. Dr. Goldstein has received intellectual property interests from a discovery or technology relating to health care. Dr. Goldstein has received publishing royalties from a publication relating to health care.
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
L C. Pettigrew, MD, MPH, FAAN No disclosure on file
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen. The institution of Dr. Evidente has received research support from Vima Pharmaceuticals. The institution of Dr. Evidente has received research support from Biohaven.
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Henry F. McFarland, MD Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Michele Tagliati, MD, FAAN Dr. Tagliati has received publishing royalties from a publication relating to health care.
Russell E. Bartt, MD, FAAN Dr. Bartt has nothing to disclose.
Richard T. Moxley III, MD, FAAN Dr. Moxley has nothing to disclose.
Jeffrey A. Kaye, MD, FAAN Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Hubert H. Fernandez, MD, FAAN Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrance. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
Blair Ford, MD, FAAN No disclosure on file
Amer Alshekhlee, MD No disclosure on file
Charles S. DeCarli, MD, FAAN Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Jerry S. Wolinsky, MD, FAAN Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Safwan S. Jaradeh, MD, FAAN Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Jaradeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam & Akcea. The institution of Dr. Jaradeh has received research support from Alnylam.
Omar A. Khan, MD, PhD No disclosure on file
John T. Kissel, MD, FAAN Dr. Kissel has nothing to disclose.
Vladimir Hachinski, MD, DSc, FAAN Dr. Hachinski has nothing to disclose.
John C. Brust, MD No disclosure on file
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Randolph S. Marshall, MD, FAAN The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Dennis N. Bourdette, MD, FAAN Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Joseph F. Quinn, MD, FAAN Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities.
Elan D. Louis, MD, MS, FAAN Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Thomas G. Brott, MD, FAAN Dr. Brott has nothing to disclose.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
David H. Miller, MD, MBChB, FRCP No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Ruth H. Whitham, MD, FAAN No disclosure on file
Ray L. Watts, MD, FAAN No disclosure on file
Andrew S. Feigin, MD Dr. Feigin has received personal compensation for serving as an employee of Rho, Inc.. Dr. Feigin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kenai. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ADCS/ATRI. Dr. Feigin has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Feigin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Feigin has received research support from Huntngton Study Group. The institution of Dr. Feigin has received research support from Prilenia.
Lael Stone, MD No disclosure on file
Richard A. Rudick, MD, FAAN Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Richard J. Caselli, MD, FAAN The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.
Fred D. Lublin, MD, FAAN Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Kenneth M. Heilman, MD, FAAN Dr. Heilman has received publishing royalties from a publication relating to health care.
James W. Schmidley, MD No disclosure on file
Jerry R. Mendell, MD, FAAN Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Elliott D. Ross, MD, FAAN No disclosure on file
Peter Como, MD No disclosure on file
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
David Eidelberg, MD, FAAN Dr. Eidelberg has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for MeiraGTx. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TreeFrog Therapeutics. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Blue Rock Therapeutics, Inc.. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANA Biotechnology, Inc. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bio Vie, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KenaiTx, Inc.. Dr. Eidelberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen Neuroscience. Dr. Eidelberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oxford University Press. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from Lupus Research Alliance. The institution of Dr. Eidelberg has received research support from National Institutes of Health. The institution of Dr. Eidelberg has received research support from Blue Rock Therapeutics. The institution of Dr. Eidelberg has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Eidelberg has received research support from The Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Eidelberg has received research support from National Institute of Allergy and Infectious Diseases. The institution of Dr. Eidelberg has received research support from Aspen Neurosciences, Inc. . The institution of Dr. Eidelberg has received research support from NIH. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Eidelberg has received intellectual property interests from a discovery or technology relating to health care.
Rajiv R. Ratan, MD, PhD No disclosure on file
Vincent Thijs, MD Dr. Thijs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Thijs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Thijs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Thijs has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Pfizer. Dr. Thijs has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim.
James F. Meschia, MD, FAAN The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Kristine Yaffe, MD Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Peter A. Calabresi, MD, FAAN Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Douglas S. Goodin, MD No disclosure on file
Howard Feldman, MD, FAAN The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Julius Latorre, MD, FAAN Dr. Latorre has nothing to disclose.
Cheryl Wall, CNP No disclosure on file
Theodore R. Brown, MD Dr. Brown has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astellas. The institution of Dr. Brown has received research support from Merck.
Vivien H. Lee, MD, FAAN Dr. Lee has nothing to disclose.
Salah G. Keyrouz, MD No disclosure on file
Renato P. Munhoz, MD, PhD Dr. Munhoz has nothing to disclose.
Vivian E. Drory, MD Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
Giancarlo Logroscino, MD, PhD, FAAN Dr. Logroscino has nothing to disclose.
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Zoe Arvanitakis, MD, MS, FAAN Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc.. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Dementia. Dr. Arvanitakis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for a private legal firm representing a governemental entity. The institution of Dr. Arvanitakis has received research support from National Institutes of Health (NIH). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with The National Institutes of Health and California State (California Institute for Regenerative Medicine or CIRM). Dr. Arvanitakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant and Educator with Summus Global, Inc.
Michael S. Okun, MD, FAAN Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
John W. Krakauer, MD No disclosure on file
Michael Hutton, PhD No disclosure on file
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Brian Bowen, MD, PhD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Steven G. Younkin, MD, PhD No disclosure on file
Leo McCluskey, MD No disclosure on file
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Joel Gutierrez, MD Dr. Gutierrez has nothing to disclose.
Ilya Kister, MD, FAAN Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Douglas M. Wallace, MD No disclosure on file
Scott B. Silverman, MD Dr. Silverman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms.
Shyam Prabhakaran, MD Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Chad R. Heatwole, MD, FAAN Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Legal Med. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $0-$499 for serving as a Consultant for Iris. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for New York Central Mutual. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Penn Prop and Gas. The institution of Dr. Heatwole has received research support from Department of Defense. The institution of Dr. Heatwole has received research support from Novartis. The institution of Dr. Heatwole has received research support from MJFF. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from University of Miami. The institution of Dr. Heatwole has received research support from MDA. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
Russell H. Swerdlow, MD No disclosure on file
Khema R. Sharma, MBBS, FAAN Dr. Sharma has nothing to disclose.
Majaz Moonis, MD, FAHA, FAAN Dr. Moonis has nothing to disclose.
Christina Caon, RN, BS Ms. Caon has received personal compensation for serving as an employee of EMD Serono.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Melissa J. Nirenberg, MD, PhD, FAAN The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. The institution of Dr. Nirenberg has received research support from American Parkinson Disease Association. An immediate family member of Dr. Nirenberg has received publishing royalties from a publication relating to health care. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation. Dr. Nirenberg has a non-compensated relationship as a Editorial board with Neurology Today that is relevant to AAN interests or activities.
Robin A. Conwit, MD, FAAN Dr. Conwit has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Sandra E. Black, MD, FAAN Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Gilles Fenelon, MD, PhD No disclosure on file
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
J. Javier Provencio, MD, FAAN Dr. Provencio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Minnetronix. The institution of Dr. Provencio has received research support from NIH NINDS.
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.
Michael D. Hill, MD Dr. Hill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Hill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sun Pharma. Dr. Hill has received stock or an ownership interest from Circle Neurovascular.
Daniel D. Truong, MD, FAAN The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
David K. Urion, MD, FAAN Dr. Urion has nothing to disclose.
Christopher Bever, Jr., MD, MBA, FAAN No disclosure on file
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Ali H. Rajput, MD, FAAN No disclosure on file
Benzi Kluger, MD, FAAN Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for International Neuropalliative Care Society. Dr. Kluger has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Palliative Medicine. The institution of Dr. Kluger has received research support from NIH. The institution of Dr. Kluger has received research support from PCORI.
Meheroz H. Rabadi, MD, FAAN Dr. Rabadi has nothing to disclose.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Marc Debouverie, MD Dr. Debouverie has nothing to disclose.
Radi S. Shahien, MD Dr. Shahien has nothing to disclose.
Pierre Krystkowiak, MD, PhD No disclosure on file
Luc Defebvre No disclosure on file
Alain Destee, MD, PhD No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Alessandro Vignola, PsyD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Paolo Ghiglione, MD No disclosure on file
No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Peachie N. Moore, BA No disclosure on file
Caroline Moreau, MD No disclosure on file
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Marie-Laure Welter No disclosure on file
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Kenkichi Nozaki, MD No disclosure on file
Julian Benito-Leon No disclosure on file
Brian A. Trimble, MD, MPH, FAAN No disclosure on file
Anne P. Lanier No disclosure on file
Felix Bermejo-Pareja, MD No disclosure on file
Yves L. Lapierre, MD No disclosure on file
Daria A. Trojan, MD No disclosure on file
Alberto Ascherio, MD, PhD Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ascherio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ascherio has received research support from NIH and US Department of Defense .
Alexis Smirnow No disclosure on file
Lineu C. Werneck, MD No disclosure on file
Helio Afonso G. Teive, MD, PhD, FAAN Dr. Teive has nothing to disclose.
John H. Wokke, MD, PhD No disclosure on file
James H. Bower, MD, MSc, FAAN The institution of Dr. Bower has received research support from Abbvie.
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Christine M. Stanley, PhD No disclosure on file
Hao Zhang, PhD No disclosure on file
Jose Luchsinger-Stuart No disclosure on file
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Hans Karbe, MD No disclosure on file
Seong B. Koh, MD No disclosure on file
Jean P. Azulay, MD Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Paolo Lamberti No disclosure on file
Isabella L. Simone No disclosure on file
Gustavo Saposnik, MD Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Alexander H. Rajput, MD, FAAN Dr. Rajput has received personal compensation in the range of $500-$4,999 for serving as a Peer reviewer with CQDM.
Gregory Crucian No disclosure on file
Dawn Bowers, PhD No disclosure on file
Maria P. Amato, PhD Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Emilio Portaccio Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Emilio Portaccio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Emilio Portaccio has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Cellgene.
Valentina Zipoli No disclosure on file
Maria Bartolozzi No disclosure on file
Maria Laura Stromillo, PhD Maria Laura Stromillo, PhD has nothing to disclose.
Leonello Guidi, MD No disclosure on file
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Antonio Federico, MD, Prof No disclosure on file
Nicola De Stefano, MD Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Healthcare KGaA. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono S.p.A. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. De Stefano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche S.p.A.. The institution of Dr. De Stefano has received research support from Italian MS Society. The institution of Dr. De Stefano has received research support from Merck Healthcare KGaA.
Colin Klein No disclosure on file
Jose M. Rabey, MD No disclosure on file
Lucette Lacomblez Aurousseau, MD No disclosure on file
Francois Salachas No disclosure on file
Ronald M. Lazar, PhD, FAHA, FAAN Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Gabriele Mora, MD Dr. Mora has nothing to disclose.
Fabrizio Salvi, MD No disclosure on file
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Maria Teresa Giordana, MD, PhD No disclosure on file
Cristina Moglia Cristina Moglia has nothing to disclose.
Raoul Morales, MD No disclosure on file
William Camu, MD No disclosure on file
Paola Valsasina Paola Valsasina has nothing to disclose.
Baziel G. van Engelen, MD, PhD, MA The institution of Dr. van Engelen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum . The institution of Dr. van Engelen has received research support from Stichting Spieren voor Spieren. The institution of Dr. van Engelen has received research support from Prinses Beatrix Fonds. The institution of Dr. van Engelen has received research support from Dutch FSHD society. Dr. van Engelen has received intellectual property interests from a discovery or technology relating to health care.
Amy R. Borenstein, PhD, FAAN No disclosure on file
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Glen R. Finney, MD, FAAN Dr. Finney has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Premier Inc. Dr. Finney has a non-compensated relationship as a Board Member with Greater Pennsylvania Chapter of the Alzheimer's Association that is relevant to AAN interests or activities.
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Mounzer Kassab, MD No disclosure on file
Pietro Tonali, MD No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Michael Schwarzschild, MD, PhD The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial Biotech (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen (indirectly, as a service of the Parkinson Study Group service). The institution of Dr. Schwarzschild has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB (indirectly, as a service of the Parkinson Study Group service). Dr. Schwarzschild has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Schwarzschild has received research support from NIH. The institution of Dr. Schwarzschild has received research support from Parkinson's Foundation. The institution of Dr. Schwarzschild has received research support from Michael J Fox Foundation. The institution of Dr. Schwarzschild has received research support from Farmer Family Foundation. Dr. Schwarzschild has a non-compensated relationship as a Chair, Executive Committee with the Parkinson Study Group that is relevant to AAN interests or activities.
Marc Weisskopf, PhD Prof. Weisskopf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kaiser Permanente Research Biobank. The institution of Prof. Weisskopf has received research support from ALS Network. The institution of Prof. Weisskopf has received research support from NIH. The institution of Prof. Weisskopf has received research support from Paralyzed Veterans of America. The institution of Prof. Weisskopf has received research support from CDC/ATSDR. The institution of Prof. Weisskopf has received research support from JPB Foundation.
David Q. Beversdorf, MD, FAAN Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yamo pharmaceuticals. Dr. Beversdorf has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier (Research in Autism Spectrum Disorders). The institution of Dr. Beversdorf has received research support from Autism Research Institute. Dr. Beversdorf has received personal compensation in the range of $5,000-$9,999 for serving as a Case Consultant with Best Doctors.
Mitch T. Wallin, MD, MPH, FAAN The institution of Dr. Wallin has received research support from NMSS.
Robert Kane, PhD, ABPP-CN No disclosure on file
Cynthia L. Sullivan, PhD No disclosure on file
Jeffrey A. Wilken, PhD No disclosure on file
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Domenico Caputo, MD No disclosure on file
Michele Perini, MD No disclosure on file
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Ramon L. Rodriguez Cruz, MD, FAAN The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Michael Hutchinson, MD Dr. Hutchinson has nothing to disclose.
Bennett L. Lavenstein, MD, FAAN No disclosure on file
Paul W. O'Connor, MD No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Kejal Kantarci, MD The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic.
Andreas Konieczny No disclosure on file
Dawn W. Langdon, PhD Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Prof. Langdon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celgene. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Prof. Langdon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. The institution of Prof. Langdon has received research support from Merck. The institution of Prof. Langdon has received research support from Novartis. The institution of Prof. Langdon has received research support from MS Society (UK). The institution of Prof. Langdon has received research support from Multiple Sclerosis Trust (UK).
George C. Ebers, MD No disclosure on file
Ja-Seong Koo, MD No disclosure on file
Jong-Moo Park, MD No disclosure on file
Ohyun Kwon No disclosure on file
Byung-kun Kim, MD Dr. Kim has nothing to disclose.
Kelly D. Foote, MD Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Mustapha A. Ezzeddine, MD, FAAN The institution of Dr. Ezzeddine has received research support from NIH.
Diane Howieson, PhD No disclosure on file
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Fen Bao Fen Bao has nothing to disclose.
Mario F. Mendez, MD, PhD, FAAN Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical Education Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Thomas J. Montine, MD, PhD Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Luc Mallet, MD, PhD No disclosure on file
Megan L. Mackenzie, DO No disclosure on file
Robert Cote, MD No disclosure on file
Jeremy S. Chataway, MD Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NerveGen. Dr. Chataway has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Vanessa Troiani No disclosure on file
Vida Demarin, MD, PhD, FAAN No disclosure on file
Margy E. McCullough-Hicks, MD Dr. McCullough-Hicks has received research support from American Academy of Neurology (Lawrence M. Brass Stroke Research Award).
Bruce R. Reed, PhD No disclosure on file
Rosebud O. Roberts, MD No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
Claudia Jacova No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Jean-Pierre Bouchard, MD, FAAN No disclosure on file
Joseph Hentz No disclosure on file
Christopher Shilling, MS No disclosure on file
Robert J. Ivnik, PhD No disclosure on file
Maria M. Shiung, BA No disclosure on file
Afshin A. Divani, PhD The institution of Dr. Divani has received research support from Department of Defense.
Maria C. Zurru, MD No disclosure on file
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Michael Kaplitt, MD No disclosure on file
Vijay Dhawan, PhD No disclosure on file
Chris H. Polman, MD No disclosure on file
Claire Henchcliffe, MD, PhD, FAAN Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.
Frederick E. Munschauer III, MD, FAAN Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
James M. Noble, MD, FAAN Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
Matthew Greenway, MD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
William H. Stuart, MD, FAAN Dr. Stuart has nothing to disclose.
Christian Confavreux, MD No disclosure on file
Michael A. Panzara, MD, MPH Dr. Panzara has received personal compensation for serving as an employee of Neurvati Neurosciences. Dr. Panzara has received personal compensation for serving as an employee of GRIN Therapeutics. Dr. Panzara has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Wave Life Sciences. Dr. Panzara has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Athira Pharma. Dr. Panzara has stock in GRIN Therapeutics. Dr. Panzara has stock in Cadenza Bio. Dr. Panzara has stock in Athira Pharma. Dr. Panzara has stock in Wave Life Sciences. Dr. Panzara has stock in Sanofi.
Joseph Herbert, MD No disclosure on file
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Dina Jacobs, MD Dr. Jacobs has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck/EMD Serono. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharmaceuticals. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi . Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving as a Consultant for William Blair &Company . Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Jacobs has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Jacobs has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . The institution of Dr. Jacobs has received research support from Roche/Genentech .
Clyde E. Markowitz, MD No disclosure on file
Wolfgang Grisold, MD, FAAN No disclosure on file
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
William J. Burke, MD, PhD, FAAN No disclosure on file
Marianne De Visser, MD, PhD Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. De Visser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca.
Andreas J. Plaitakis, MD No disclosure on file
Anthony Reder, MD Dr. Reder has nothing to disclose.
Michael Hoffmann, MD, FCP, FAHA, FAAN No disclosure on file
Kun W. Park, MD, PhD No disclosure on file
Agnes Jani-Acsadi, MD No disclosure on file
Perttu J. Lindsberg, MD The institution of Dr. Lindsberg has received research support from Helsinki University Hospital District. The institution of Dr. Lindsberg has received research support from Sigrid Juselius foundation.
Antonio Giorgio, MD Dr. Giorgio has nothing to disclose.
Tatiana Witjas No disclosure on file
Richard K. Kim, MD Dr. Kim has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for RKK Consulting, Inc..
Carl Granger No disclosure on file
Jeffery Gunter The institution of Jeffery Gunter has received research support from NIH. Jeffery Gunter has received intellectual property interests from a discovery or technology relating to health care.
Stephen Weigand Stephen Weigand has nothing to disclose.
Peter C. O'Brien, PhD No disclosure on file
Scott Przybelski Scott Przybelski has nothing to disclose.
Stefano Bastianello No disclosure on file
Linda Winfield, RN No disclosure on file
Seth L. Pullman, MD, FAAN No disclosure on file
Dan M. Mungas, PhD Dr. Mungas has nothing to disclose.
Sayed A. Azizi, MD, PhD, FAAN No disclosure on file
Stephanie Cantiniaux No disclosure on file
Vasileios Mastorodemos, MD No disclosure on file
Ellen M. Mowry, MD, FAAN Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Harrison C. Walker III, MD Dr. Walker has nothing to disclose.
Barton Guthrie No disclosure on file
Jennifer Whitwell, PhD The institution of Dr. Whitwell has received research support from NIH.
Mohammed Rehman, DO Dr. Rehman has nothing to disclose.
Sherine Abboud, MD, PhD No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Cecilia Serrano No disclosure on file
Moira Kapral, MD The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
Fernando Taragano No disclosure on file
Carole Dufouil, PhD No disclosure on file
Christophe Tzourio, MD, PhD No disclosure on file
Marcelo F. Rugiero, MD No disclosure on file
Clinton B. Wright, MD, FAAN An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Nikolaos Scarmeas, MD, FAAN Dr. Scarmeas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Albert Einstein Collego of Medicine. The institution of Dr. Scarmeas has received research support from NovoNordisc. The institution of Dr. Scarmeas has received research support from European Union Horizon Projects. The institution of Dr. Scarmeas has received research support from Hellenic Foundation for Research & Innovation .
Mingxin Tang, PhD No disclosure on file
Ophelia Godin No disclosure on file
Todd Constable Todd Constable has nothing to disclose.
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Jean-Francois Dartigues, PhD No disclosure on file
Rachel Whitmer, PhD Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech . Dr. Whitmer has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's and Dementia:Journal of the Alzheimer's Association . The institution of Dr. Whitmer has received research support from National. Institute of Health .
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Lisa Silbert, MD, FAAN The institution of Dr. Silbert has received research support from the NIH. Dr. Silbert has received personal compensation in the range of $0-$499 for serving as a Peer Reviewer, study section with NIH.
Warren W. Barker, MA No disclosure on file
Jeannette A. Barrett, PhD No disclosure on file
Francesca Bagnato, MD Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Bagnato has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyne. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jenseen. Dr. Bagnato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk-Serono.
Joan M. Ohayon Joan M. Ohayon has nothing to disclose.
Vasiliki N. Ikonomidou No disclosure on file
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Chris Tang, MD No disclosure on file
Pinky H. Agarwal, MD, FAAN Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Dale J. Lange, MD, FAAN No disclosure on file
Kwok-Keung Tai No disclosure on file
William J. Litchy, MD, FAAN Dr. Litchy has nothing to disclose.
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Ranjan Duara, MD Dr. Duara has nothing to disclose.
Cornelia Mihai, MD, FAAN Dr. Mihai has nothing to disclose.
Paul E. Schulz, MD Dr. Schulz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisa .
James A. Mortimer, PhD, FAAN No disclosure on file
Ammar Al Kawi, MD, FAAN Dr. Al Kawi has nothing to disclose.
George Dale George Dale has nothing to disclose.
Roi A. Wallis, MD No disclosure on file
James E. Hilbert, MS Mr. Hilbert has nothing to disclose.
Leonard van den Berg, MD The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ferrrer. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. The institution of Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Projenx. Dr. Van den Berg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Van den Berg has received research support from Netherlands ALS Foundation.
Frans Brugman, MD No disclosure on file
Andrea Vincent Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
Kachikwu O. Illoh, MD No disclosure on file
Eric M. Reiman, MD Dr. Reiman has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali, Green Valley, Zinfandel, and Takeda. Dr. Reiman has received stock or an ownership interest from Alkahest, Alzheon, Aural Analytics, Denali, and United Neuroscience.. Dr. Reiman has received intellectual property interests from a discovery or technology relating to health care. Dr. Reiman has received personal compensation in the range of $500-$4,999 for serving as a Member, National Advisory Council on Aging (NACA) with NIA.
Michael Dobbs, MD Dr. Dobbs has received publishing royalties from a publication relating to health care.
Gabriel R. De Freitas, MD, PhD Dr. De Freitas has nothing to disclose.
Charles Andre, MD No disclosure on file
Alida F. Griffith, MD No disclosure on file
Jose L. Ruiz-Sandoval, MD Dr. Ruiz-Sandoval has nothing to disclose.
Fernando Barinagarrementeria, MD, FAAN No disclosure on file
Erwin Chiquete, MD, PhD No disclosure on file
Carolina Leon Jimenez, MD No disclosure on file
Antonio Arauz, MD, PhD Dr. Arauz has nothing to disclose.
Richard A. Hughes, MD Dr. Hughes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi.
Melinda S. Burnett, MD Dr. Burnett has a non-compensated relationship as a Reviewer with Neurology Clinical Practice that is relevant to AAN interests or activities.
Vijay K. Sharma, MD No disclosure on file
Sushant P. Kale, MD No disclosure on file
Jesus Lovera, MD Dr. Lovera has nothing to disclose.
Honglei Chen, MD, PhD, FAAN The institution of Dr. Chen has received research support from NIH, . The institution of Dr. Chen has received research support from DoD. The institution of Dr. Chen has received research support from Parkinson's Foundation. The institution of Dr. Chen has received research support from MSU GE and Gibby vs. Parky project.
John M. Ringman, MD, FAAN The institution of Dr. Ringman has received research support from Avid Pharmaceuticals. The institution of Dr. Ringman has received research support from AltaMed. The institution of Dr. Ringman has received research support from CurePSP.
Nicole Gonzales, MD The institution of Dr. Gonzales has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Simon Cronin, PhD Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Yves Samson, MD No disclosure on file
Peter J. Koudstaal, MD No disclosure on file
Albert Hofman, MD, PhD No disclosure on file
Monique M. Breteler, MD, PhD No disclosure on file
Shree Pandya, DPT No disclosure on file
Amy Pace, ScD No disclosure on file
Mandeep Garewal, MD Dr. Garewal has nothing to disclose.
Arousiak V. Maraian, MD No disclosure on file
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Wim L. Robberecht, MD, PhD No disclosure on file
Raju Kapoor, MD No disclosure on file
Stephen J. Ryan, MD No disclosure on file
Robert Hyde, PhD Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Robert A. Bornstein, PhD No disclosure on file
Anita Datta, MD No disclosure on file
Helenius J. Schelhaas, MD No disclosure on file
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Ed Whalen Ed Whalen has received personal compensation for serving as an employee of Pfizer. Ed Whalen has stock in Pfizer.
Amanda VanDenburgh No disclosure on file
Mitchell F. Brin, MD, FAAN Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
Ihtsham Haq, MD, FAAN The institution of Dr. Haq has received research support from NINDS. The institution of Dr. Haq has received research support from the Parkinson's Foundation.
Latha Ganti, MD, MS, MBA, FACEP Dr. Ganti has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Ganti has received publishing royalties from a publication relating to health care.
Wyatt W. Decker No disclosure on file
Miia Kivipelto, MD No disclosure on file
Anand Vaishnav, MD No disclosure on file
Maria Kataki, MD, PhD, FAAN No disclosure on file
Laura R. Ment, MD No disclosure on file
Walter R. Royal III, MD No disclosure on file
Steven W. Johnson, MD, PhD No disclosure on file
Osvaldo Fustinoni, MD No disclosure on file
Vincent Meininger, MD, PhD No disclosure on file
Walter F. Haupt, MD, Prof, FAAN No disclosure on file
Michel Poncet, MD, PhD No disclosure on file
Gordon J. Gubitz, MD No disclosure on file
Anthony P. Nicholas, MD, PhD Dr. Nicholas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fenwick. Dr. Nicholas has received publishing royalties from a publication relating to health care.
Mohammad Wasay, MBBS, FAAN Dr. Wasay has nothing to disclose.
Michael R. Rose, MD No disclosure on file
Maria R. Tola, MD No disclosure on file
Exuperio Diez-Tejedor, MD, PhD No disclosure on file
Seong H. Choi, MD, PhD No disclosure on file
Francesco Patti, MD Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Almirall. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Patti has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Almirall, Bayer, Biogen, Bristol Meyers and Squibb Merck, Roche, Sanofi, TEVA. Dr. Patti has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for University of Catania and AISM/FISM, Fondazione Italiana Sclerosi Multipla. Dr. Patti has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology.
Paolo Livrea No disclosure on file
Anahita F. Deboo, MD Dr. Deboo has nothing to disclose.
Neville Bayer No disclosure on file
Maria M. Esnaola Y Rojas, MD Dr. Esnaola Y Rojas has nothing to disclose.
Jeffrey M. Burns, MD Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
Daniel Antoniello, MD Dr. Antoniello has nothing to disclose.
Gaelle Bruneteau, MD No disclosure on file
Srikanth Muppidi, MD, FAAN Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care.
Zulfi Haneef, MD, MBBS, MRCP, FAAN Dr. Haneef has received publishing royalties from a publication relating to health care.
Preetha Muthusamy, MD No disclosure on file
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Lesley M. Arnold, MD No disclosure on file
Joshua Bacon, PhD No disclosure on file
M. Fernanda Bellolio, MD No disclosure on file
Mohamad Chmayssani, MD No disclosure on file
Sally Chang No disclosure on file
Shu-Ing Chang No disclosure on file
Curie Chung, MD No disclosure on file
William J. Culpepper II, PhD, MA No disclosure on file
Brittany Dugger, BS No disclosure on file
Sailaja Enduri, MD No disclosure on file
Gereon Fink No disclosure on file
Joseph Finkelstein No disclosure on file
Sarah Farias No disclosure on file
Kamayani Khare, MD No disclosure on file
Jung-Ju Lee, MD, PhD No disclosure on file
Tanya Lin, MD Dr. Lin has nothing to disclose.
Pauline Maillard, PhD Dr. Maillard has nothing to disclose.
Dulka Manawadu, MD No disclosure on file
Jungmoo Nam, MD No disclosure on file
Mai Yamakawa, MD Dr. Yamakawa has nothing to disclose.
Jonathan Peelle No disclosure on file
Luis D. Medina, PhD The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Jee Hoon Roh, MD, PhD No disclosure on file
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Angela Y. Shih, MD, MS, MPH No disclosure on file
Paul Mattis Paul Mattis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meiragtx.
George Thomas No disclosure on file
Prashanthi Vemuri, PhD The institution of Dr. Vemuri has received research support from NIH.
Tanya Harlow, MD, FAAN Dr. Harlow has nothing to disclose.
Reza Seyedsadjadi, MD Dr. Seyedsadjadi has received personal compensation for serving as an employee of American Neurological Association. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio Therapeutics. Dr. Seyedsadjadi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Seyedsadjadi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Seyedsadjadi has received research support from Cystinosis Research Foundation.
Barbara S. Pedley, MD, FAAN No disclosure on file
Vijayshree Yadav, MD, FAAN Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Geoffrey Ahern, MD, PhD Dr. Ahern has nothing to disclose.
Lisa L. Barnes, PhD Lisa L. Barnes has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer's & Dementia. The institution of Lisa L. Barnes has received research support from NIH. Lisa L. Barnes has received personal compensation in the range of $500-$4,999 for serving as a Council member with NACMHD.
Iram Zaman, DO, FAAN Dr. Zaman has nothing to disclose.
Steven Z. Rapcsak, MD Dr. Rapcsak has nothing to disclose.
Daniel Bandari, MD The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Bandari has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD-Serono. The institution of Dr. Bandari has received research support from Genentech. The institution of Dr. Bandari has received research support from EMD-Serono.
France Woimant, MD No disclosure on file
Charles Pierrot-Deseilligny, MD No disclosure on file
Jennifer J. Manly, PhD The institution of Dr. Manly has received research support from NIH. Dr. Manly has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with University of Mississippi.
Jeffrey Minuk, MD No disclosure on file
Joung-Ho Rha, MD, PhD No disclosure on file
Choong-Kun Ha, MD No disclosure on file
Stephen J. Phillips, MBBS No disclosure on file
Xiomara Q. Rosales, MD No disclosure on file
MaryLynn Chu, MD Dr. Chu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics; PTC Therapeutics,Inc..
Beth K. Rush, PhD Dr. Rush has nothing to disclose.
Barbara Teter, PhD MPH No disclosure on file
Nandakumar Bangalore Vittal, MD No disclosure on file
Wei Tang, MD, PhD No disclosure on file
Chin-Sang Chung, MD, PhD No disclosure on file
Gyeong-Moon Kim, MD No disclosure on file
Antonio G. Gallo, MD No disclosure on file
Stanley Tuhrim, MD No disclosure on file
Jesse Weinberger, MD No disclosure on file
Fredric K. Cantor, MD, FAAN No disclosure on file
Michael Pourfar, MD Dr. Pourfar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Pourfar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott.
Luisa Vesely No disclosure on file
Erwin B. Montgomery, Jr., MD No disclosure on file
Sudhakar Tummala, MD, FAAN Dr. Tummala has nothing to disclose.
Karola Beckmann No disclosure on file
Robert Brenner, FRCP No disclosure on file
Eva-Maria Wicklein, MD Dr. Wicklein has received personal compensation for serving as an employee of Bayer AG.
Monica M. Kurtis, MD No disclosure on file
Alison Cernich No disclosure on file
Sean Scott No disclosure on file
Alexander Shtilbans, MD, PhD, FAAN Dr. Shtilbans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Medicine. Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal Pharmaceuticals. Dr. Shtilbans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Shtilbans has received research support from Praxis Medicine.
Negar Asdaghi, MD Dr. Asdaghi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Brandon R. Barton, MD, FAAN Dr. Barton has nothing to disclose.
Monique L. D'Amour, MD No disclosure on file
Sashank Prasad, MD Dr. Prasad has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Medicolegal firms. Dr. Prasad has received publishing royalties from a publication relating to health care.
Aarti Sarwal, MD, FAAN Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to AAN interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to AAN interests or activities.
Charlotte Rosso No disclosure on file
Timothy J. Mikesell, DO No disclosure on file
Albert K. Akpalu, MD Dr. Akpalu has nothing to disclose.
Gerald Pfeffer, MD, PhD Dr. Pfeffer has received research support from Canadian Institutes of Health Research.
Jeroen Trip, MD No disclosure on file
Gea Drost, MD, PhD No disclosure on file
Christiane Reitz, MD, PhD No disclosure on file
Gisella Gargiulo Monachelli, MD, PhD No disclosure on file
Gabriel Rodriguez, MD No disclosure on file
Roberto Sica, MD, PhD No disclosure on file
Joanna E. Bielewicz, PhD Dr. Bielewicz has nothing to disclose.
Halina Bartosik-Psujek No disclosure on file
Urzula Chyrchel, PhD No disclosure on file
Zbigniew Stelmasiak, PhD No disclosure on file
Leslie C. Baxter, PhD No disclosure on file
Derya Kaya No disclosure on file
Smitha Suravaram No disclosure on file
Luigi M. Specchio No disclosure on file
Eustachio D'Errico No disclosure on file
Wei Liu Wei Liu has received personal compensation for serving as an employee of AbbVie. Wei Liu has received stock or an ownership interest from AbbVie.
Jan Sobesky, MD No disclosure on file
Gabriele Siciliano Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Andrew Russman, DO, FAAN Dr. Russman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific Corporation. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Russman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Christel Renoux No disclosure on file
W.Ludo Vanderpol, MD No disclosure on file
Suzanne Babyar No disclosure on file
Michael J. Reding, MD No disclosure on file
Kenneth S. Butcher, MD, PhD No disclosure on file
Semi Oh No disclosure on file
Kwang H. Lee, MD No disclosure on file
Carlo S. Tornatore, MD Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Bruce T. Volpe, MD, FAAN No disclosure on file
Eunme Cha No disclosure on file
Helene Brissart No disclosure on file
Marianne Leroy No disclosure on file
Allison Drake No disclosure on file
Charlotte Crinquette No disclosure on file
Bruno Lenne, PhD No disclosure on file
Alexandre Mackowiak, MD No disclosure on file
Patrick Hautecoeur No disclosure on file
Massimo Corbo No disclosure on file
Maurizio Leone, MD Dr. Leone has nothing to disclose.
Edo Bottacchi No disclosure on file
Abdul Malik, MD, FAAN No disclosure on file
Danish Bhatti, MD, FAAN Dr. Bhatti has nothing to disclose.
Pascal Favrole, MD No disclosure on file
Sung Rae Kim, MD No disclosure on file
So-Hyun Kim, MD No disclosure on file
Jeong Lee, MD No disclosure on file
Ki-Hwan Ji, MD No disclosure on file
Horng-Huei Liou, MD No disclosure on file
Ta-fu Chen No disclosure on file
Chin-San Liu No disclosure on file
Nobuko Hirota No disclosure on file
Kuni Konaka No disclosure on file
Scott Norris, MD The institution of Dr. Norris has received research support from NIH, DMRF, Dysphonia International.
Tiina Sairanen, MD No disclosure on file
Christine Cowles No disclosure on file
David S. Lynch, MBBS, PhD Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis.
Sanne Piepers No disclosure on file
Jacqueline Van Der Wielen-Jonge, MD No disclosure on file
Michael Klufas No disclosure on file
Tatiana Zaldivar Vaillant, MD No disclosure on file
Brandon M. Minzer No disclosure on file
Galeno Rojas, MD No disclosure on file
Valeria Battistella, MD, PhD No disclosure on file
Shih-Chieh Yu No disclosure on file
Ilaria Bartolomei No disclosure on file
MariaClaudia Vigliani No disclosure on file
Alina Solomon No disclosure on file
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Mitra Ameli, MD No disclosure on file
Domenico De Lucia No disclosure on file
Ronald O. Bailey, MD No disclosure on file
Jennifer Vannest No disclosure on file
Teresa Leon, MD, PhD Dr. Leon has received personal compensation for serving as an employee of Novo Nordisk A/S Copenhagen. Dr. Leon has stock in Novo Nordisk. Dr. Leon has stock in Pharma Mar.
Iordanis Evangelou No disclosure on file
Hao Wang, PhD No disclosure on file
Mazen Jabre, PharmD, BCPP No disclosure on file
Paul W. Bejjani, MD No disclosure on file
Renea M. Sturm No disclosure on file
Nathaniel D. Mercaldo No disclosure on file
Tom Hayton No disclosure on file
Kevin E. Hunter, MD No disclosure on file
Shira Kurtz No disclosure on file
Heidi W. Maloni No disclosure on file
Tobias Walbert, MD, PhD, FAAN Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Stacey Cofield No disclosure on file
Olivier Casez, MD Dr. Casez has nothing to disclose.
Phil You No disclosure on file
Judy H. Lichtman, PhD, MPH No disclosure on file
Norrina Allen, PhD The institution of Norrina Allen has received research support from NIH. The institution of Norrina Allen has received research support from AHA. Norrina Allen has received personal compensation in the range of $0-$499 for serving as a OSMB member with NIH.
Cristina Duran No disclosure on file
Adriana M. Strutt, PhD No disclosure on file
Marijana Lisak, MD, PhD No disclosure on file
Sandra Morovic, MD, PhD No disclosure on file
Nadir A. Syed, MD No disclosure on file
Hannah Gardener, ScD Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Raquel Gardner, MD Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Julie Pilitsis Julie Pilitsis has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Julie Pilitsis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aim Medical Robotics . Julie Pilitsis has stock in Aim Medical Robotics . The institution of Julie Pilitsis has received research support from Medtronic. The institution of Julie Pilitsis has received research support from Boston Scientific. The institution of Julie Pilitsis has received research support from Abbott. The institution of Julie Pilitsis has received research support from Focused Ultrasound Foundation. The institution of Julie Pilitsis has received research support from NIH 2R01CA166379. The institution of Julie Pilitsis has received research support from NIH R01EB030324. The institution of Julie Pilitsis has received research support from NIH-NeuroBlueprint MedTech 5U54EB033650.
Isabelle Barnaure No disclosure on file
Olivier Moreaud No disclosure on file
Marc A. Lazzaro, MD No disclosure on file
Ashvini P. Premkumar, MD No disclosure on file
Sarada Sakamuri, MD, FAAN Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with AANEM. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with ISNMI Neuromuscular Ultrasound Workshop. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University.
Rebecca McNeil No disclosure on file
Jennifer E. Vaughan, MD No disclosure on file
Connie C. Marras, MD Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Bagar A. Husaini No disclosure on file
Marc Sollberger, MD No disclosure on file
Lauren Saunders No disclosure on file
Amy Fothergill No disclosure on file
Rolf Martin No disclosure on file
Michael McCaffrey, MD No disclosure on file
Jose Ramon Ara, MD No disclosure on file
Jose L. Capablo No disclosure on file
Jesus Martin No disclosure on file
William K. Seltzer, PhD No disclosure on file
Craig M. Zaidman, MD Dr. Zaidman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for sarepta. The institution of Dr. Zaidman has received research support from Washington University in St Louis. The institution of Dr. Zaidman has received research support from Novartis.
Monique M. Williams, MD No disclosure on file
Gregory F. Molnar, PhD No disclosure on file
Gabriela Miyazawa No disclosure on file
Michael Wheaton No disclosure on file
Glenn D. Graham, MD, PhD, FAAN Dr. Graham has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker with MER (non-profit CME provider). Dr. Graham has received personal compensation in the range of $500,000-$999,999 for serving as a Employee with Department of Veterans Affairs. An immediate family member of Dr. Graham has received personal compensation in the range of $100,000-$499,999 for serving as a Exployee with Department of Veterans Affairs.
Kasey L. Gildersleeve, MD No disclosure on file
Babak Navi, MD Dr. Navi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MindRhythm Inc. Dr. Navi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medicolegal firms.
Cyrus Boelman, MD No disclosure on file
Nerses Bebek, MD, PhD Dr. Bebek has nothing to disclose.
Mariela Bettini, MD Dr. Bettini has nothing to disclose.
Marija Bosnjak-Pasic, PhD No disclosure on file
Elisa Canu The institution of Elisa Canu has received research support from Italian Ministry of Health .
Sushrut Dharmadhikari, MD Dr. Dharmadhikari has nothing to disclose.
Maria Raquel Lopez, MD, FAAN Dr. Lopez has nothing to disclose.
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has nothing to disclose.
Christina Mijalski, MD, MPH Dr. Mijalski has nothing to disclose.
Armistead Williams III, MD Dr. Williams has nothing to disclose.
Joao A. Gomes, MD Dr. Gomes has nothing to disclose.
Rita Bella No disclosure on file
Giovanni Pennisi, MD No disclosure on file
Julie Roth, MD, FAAN Dr. Roth has nothing to disclose.
Jayashree Sundararajan, MD Dr. Sundararajan has nothing to disclose.
Mitchell G. Miglis, MD, FAAN Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care.
Muhib Khan, MD, FAAN The institution of Dr. Khan has received research support from Mayo Clinic Education Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Gorazd B. Stokin, MD, PhD, FAAN Dr. Stokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Terumo. Dr. Stokin has received research support from CNS.
Henry Houlden No disclosure on file
Marcelo Chaves No disclosure on file
Massimiliano Copetti No disclosure on file
Giuseppe Lanza, MD No disclosure on file
Elka Stefanova No disclosure on file
Michael D. Fox, MD, PhD Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Wallace Brownlee, MD Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Brownlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Fawzi Babtain, MD Dr. Babtain has nothing to disclose.
Rocio Hernandez Clares, MD, PhD No disclosure on file
Prakash R. Paliwal, MD No disclosure on file
John Tzartos, MD No disclosure on file
Umberto Manera, MD Dr. Manera has nothing to disclose.
Lawrence M. Samkoff, MD, FAAN Dr. Samkoff has nothing to disclose.
Rajat Lahoria, MD No disclosure on file
Jasem Y. Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Joash T. Lazarus, MD Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers squib. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for USWM. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for arcadia. Dr. Lazarus has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for acorda. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lazarus has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for allergan. The institution of Dr. Lazarus has received research support from Genentech.
Rawan Albadareen, MD Dr. Albadareen has nothing to disclose.
Scott T. Demarest, MD The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Demarest has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capsida. The institution of Dr. Demarest has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mahzi. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for neurocrine. The institution of Dr. Demarest has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. The institution of Dr. Demarest has received research support from NIH. Dr. Demarest has a non-compensated relationship as a SMAB with SLC6A1 Connect that is relevant to AAN interests or activities. Dr. Demarest has a non-compensated relationship as a SMAB with Ring 14 USA that is relevant to AAN interests or activities. Dr. Demarest has a non-compensated relationship as a SMAB with FamilieSCN2A that is relevant to AAN interests or activities.
Narges Moghimi, MD Dr. Moghimi has nothing to disclose.
Syed F. Ali, MD No disclosure on file
Simon Laganiere, MD Dr. Laganiere has nothing to disclose.
Scott R. Haines, MD No disclosure on file
Rahul H. Dave, MD, PhD No disclosure on file
Scott M. Belliston, DO Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech.
Mohamad Ezzeldin, MD Dr. Ezzeldin has nothing to disclose.
Malihe Rivaz, MD No disclosure on file
Gurmeen Kaur, MBBS Dr. Kaur has nothing to disclose.
Angelia Kirkpatrick Angelia Kirkpatrick has nothing to disclose.
Anna Pink, PhD No disclosure on file
Leslie Guthery Leslie Guthery has nothing to disclose.
Sameer Sharma, MD, MBBS Dr. Sharma has nothing to disclose.
John F. Kurtzke, MD No disclosure on file
Henrikas Vaitkevicius, MD Dr. Vaitkevicius has received personal compensation for serving as an employee of Noema Pharmaceuticals. Dr. Vaitkevicius has stock in Noema Pharmaceuticals.
Ari M. Wachsman, MD No disclosure on file
Jennifer L. Marsella, MD Dr. Marsella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed, EBSCO Information Services. Dr. Marsella has received personal compensation in the range of $500-$4,999 for serving as a Content Contributor with the American Academy of Neurology.
Ivan Da Silva, MD Dr. Da Silva has nothing to disclose.
Richard R. Darby, MD Dr. Darby has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for criminal forensic cases. The institution of Dr. Darby has received research support from National Institutes of Health.
E. Alexandra Brown, MD Dr. Brown has nothing to disclose.
Murat Aksu, MD No disclosure on file
Mohammad I. Hirzallah, MD Dr. Hirzallah has nothing to disclose.
Neal S. Parikh, MD Dr. Parikh has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Parikh has or had stock in Alnylam Pharmaceuticals.
Dhanya Vijayakumar, MD No disclosure on file
Diane Stephenson Diane Stephenson has received personal compensation for serving as an employee of Critical Path Institute.
Michael G. Erkkinen, MD Dr. Erkkinen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.
Carly P. Scatton, DO No disclosure on file
Natasa Dragicevic, MD, PhD No disclosure on file
Bernard P. Chan, MD The institution of Dr. Chan has received research support from National University Hospital, Singapore.
Janina Krell-Roesch, PhD Dr. Krell-Roesch has nothing to disclose.
Anna Bank, MD Dr. Bank has nothing to disclose.
Maya S. Graham, MD The institution of Dr. Graham has received research support from the A. James and Alice B. Clark Foundation. The institution of Dr. Graham has received research support from NINDS.
Kunakorn Atchaneeyasakul, MD No disclosure on file
Samar F. Ahmed, MD Dr. Ahmed has nothing to disclose.
Hannah Park, MD Dr. Park has received personal compensation in the range of $0-$499 for serving as a Consultant for Pfizer. Dr. Park has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer.
Marta Simone Marta Simone, 11772 has nothing to disclose.
Joseph C. Griffis No disclosure on file
Michelle S. Nunes, Sr., MD Dr. Nunes has nothing to disclose.
Asaf Honig, MD No disclosure on file
Marco Pisa, MD Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Sung Yim, MD No disclosure on file
Maximilian Berger No disclosure on file
Mary B. Connolly, MD Dr. Connolly has nothing to disclose.
Michelle Demos, MD No disclosure on file
Kevin O'brien No disclosure on file
Linda Huh, MD No disclosure on file
Aspasia Michoulas, MD No disclosure on file
Tanya Nelson, PharmD No disclosure on file
Hema R. Gajula, MD No disclosure on file
Sami H. Moshi, MD No disclosure on file
Jennifer J. Choi, MD No disclosure on file
Ima M. Ebong, MD, FAAN The institution of Dr. Ebong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Ebong has received research support from Ad Scientiam.
Alyssa R. Thomas, BA No disclosure on file
Lily Wong, RN No disclosure on file
Ester Carreon Guarnizo Ester Carreon Guarnizo has nothing to disclose.
Maria Cerdan Sanchez No disclosure on file
Anna Grisold, MD No disclosure on file
Kevin N. Ramdas, MD No disclosure on file
Louisa C. Boyd No disclosure on file
Sarah E. Buerki, MD No disclosure on file
Chiew Hong No disclosure on file
Cheryl Lacadie Cheryl Lacadie has nothing to disclose.
George C. Malatinszky, MD No disclosure on file
Marna McKenzie No disclosure on file
Clara Van Karnebeek No disclosure on file
Jia Wei Woo No disclosure on file